Tag
Anthropic AI announced that Claude successfully designed novel protein binders for 14 out of 15 drug targets, with independent verification by Adaptyv Bio and Twist Bioscience.
Nabla Bio unveils JAM-2, a model for zero-shot drug design achieving atomic-precision, computationally designed multispecific antibodies and dual-variant KRAS multispecifics with high potency and selectivity, validated with Cryo-EM and wet-lab experiments.
APCyc is a target-aware generative framework that designs cyclic peptides with controlled physicochemical properties by explicitly modeling cyclization patterns and using Bayesian posterior guidance.